Josh Walker
, Assistant Director · Oregon Health & Science University
Credentials: · · · ·
History
- 2013–2014
Preliminary or Transitional Year
Research
OX40 is a potent immune-stimulating target in late-stage cancer patients
Cancer Research · 2013 · 396 citations
Journal of Immunotherapy · 2006 · 40 citations
Journal for ImmunoTherapy of Cancer · 2020 · First of 9 authors · Corresponding · 28 citations
2 papers
- NN
2 papers
- WU
2 papers
1 paper
1 paper
- AB
1 paper
- AG
1 paper
1 paper · 1 as a fellow
